CH1391448177
CH1391448177
BEONE MEDICINES
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 310B EUR | 250.44B EUR | 247.98B EUR | 258.96B EUR |
Enterprise Value | 306.77B EUR | 246.49B EUR | 244.33B EUR | 255.51B EUR |
Valuation Multiples | ||||
Trailing P/E | 62.38x | 381.94x | 483.37x | 906.53x |
Forward P/E | 30.56x | -- | -- | -- |
Price to Sales | 50.58x | 40.86x | 43.21x | 61.28x |
Price to Book | 7.58x | 48.4x | 52.09x | 59.38x |
EV/Revenue | 50.05x | 40.22x | 42.57x | 60.46x |
EV/EBITDA | 286.27x | 209.72x | 263.92x | 431.22x |
Price to FCF (P/FCF) | 352.66x | 191.33x | 226.69x | 277.45x |
EV/FCF | 348.99x | 188.3x | 223.36x | 273.74x |
FCF Yield | 0.28% | 0.52% | 0.44% | 0.36% |